Novartis AG
A Pharmaceutical Composition Comprising An Oxazine Derivative And Its Use In The Treatment Or Prevention Of Alzheimer's Disease
Last updated:
Abstract:
The present invention relates to a pharmaceutical composition comprising an oxazine derivative BACE-1 inhibitor, a process for the preparation thereof, and its use in the treatment or prevention of Alzheimer's disease.
Status:
Application
Type:
Utility
Filling date:
18 Jan 2018
Issue date:
26 Dec 2019